170 related articles for article (PubMed ID: 17229867)
41. Comparison of beta-lactams in counter-selecting resistance of Pseudomonas aeruginosa.
Tam VH; Schilling AN; Melnick DA; Coyle EA
Diagn Microbiol Infect Dis; 2005 Jun; 52(2):145-51. PubMed ID: 15964503
[TBL] [Abstract][Full Text] [Related]
42. [Susceptibility to chemotherapeutics and the occurrence of metallo-beta-lactamases in hospital Pseudomonas aeruginosa strains].
Nowak P; Targosz A; Budak A; Oleksiak D; Geza G; Skałkowska M
Med Dosw Mikrobiol; 2006; 58(3):231-7. PubMed ID: 17340998
[TBL] [Abstract][Full Text] [Related]
43. [Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005].
Yang QW; Xu YC; Chen MJ; Hu YJ; Ni YX; Sun JY; Yu YS; Kong HS; He L; Wu WY; Ye HF; Yang YM; Zhu LN; Guo SH; Ji P; Zhu ZH; Ren JK; Zhang LX; Sun ZY; Zhu XH; Tong MQ; Zhao WS; Mei YN; Liu Y; Zhang ZJ; Duan Q; Li D; Liu PP; Wang J; Han LX; Wang H; Xie XL
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2753-8. PubMed ID: 18167265
[TBL] [Abstract][Full Text] [Related]
44. Pharmacodynamic target attainment of six beta-lactams and two fluoroquinolones against Pseudomonas aeruginosa, Acinetobacter baumannii, Escherichia coli, and Klebsiella species collected from United States intensive care units in 2004.
DeRyke CA; Kuti JL; Nicolau DP
Pharmacotherapy; 2007 Mar; 27(3):333-42. PubMed ID: 17316145
[TBL] [Abstract][Full Text] [Related]
45. Detection of carbapenem resistance in clinical mucoid Pseudomonas aeruginosa isolates.
Horii T; Adachi A; Morita M
Scand J Infect Dis; 2009; 41(11-12):873-6. PubMed ID: 19922072
[TBL] [Abstract][Full Text] [Related]
46. Susceptibility testing of Pseudomonas aeruginosa by the Vitek 2 system: a comparison with Etest results.
Saegeman V; Huynen P; Colaert J; Melin P; Verhaegen J
Acta Clin Belg; 2005; 60(1):3-9. PubMed ID: 15981697
[TBL] [Abstract][Full Text] [Related]
47. [Evaluation of methods for studying susceptibility to oxacillin and penicillin in 60 Staphylococcus lugdunensis isolates].
Batista N; Fernández MP; Lara M; Laich F; Méndez S
Enferm Infecc Microbiol Clin; 2009 Mar; 27(3):148-52. PubMed ID: 19306714
[TBL] [Abstract][Full Text] [Related]
48. Performance evaluation of the BD phoenix automated microbiology system in meropenem susceptibility testing of clinical Pseudomonas aeruginosa isolates.
Bayramoglu G; Acuner IC; Sinirtas M; Gedikoglu S; Durupinar B
Saudi Med J; 2006 Dec; 27(12):1921-3. PubMed ID: 17143380
[No Abstract] [Full Text] [Related]
49. Comparison of Phoenix and VITEK 2 extended-spectrum-beta-lactamase detection tests for analysis of Escherichia coli and Klebsiella isolates with well-characterized beta-lactamases.
Thomson KS; Cornish NE; Hong SG; Hemrick K; Herdt C; Moland ES
J Clin Microbiol; 2007 Aug; 45(8):2380-4. PubMed ID: 17596369
[TBL] [Abstract][Full Text] [Related]
50. Beta-lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres).
Dubois V; Arpin C; Dupart V; Scavelli A; Coulange L; André C; Fischer I; Grobost F; Brochet JP; Lagrange I; Dutilh B; Jullin J; Noury P; Larribet G; Quentin C
J Antimicrob Chemother; 2008 Aug; 62(2):316-23. PubMed ID: 18467306
[TBL] [Abstract][Full Text] [Related]
51. False susceptibility to cefotetan reported by MicroScan for DHA-type AmpC beta-lactamase-producing Klebsiella pneumoniae.
Lee SY; Park YJ; Oh EJ; Yoo JK; Park JJ; Park KG; Han K
Clin Microbiol Infect; 2007 May; 13(5):539-41. PubMed ID: 17331122
[TBL] [Abstract][Full Text] [Related]
52. Susceptibility patterns of clinical and fish isolates of Laribacter hongkongensis: comparison of the Etest, disc diffusion and broth microdilution methods.
Lau SK; Wong GK; Poon RW; Lee LC; Leung KW; Tse CW; Ho PL; Que TL; Woo PC; Yuen KY
J Antimicrob Chemother; 2009 Apr; 63(4):704-8. PubMed ID: 19202149
[TBL] [Abstract][Full Text] [Related]
53. Antimicrobial resistance among clinical isolates of Pseudomonas aeruginosa from patients in a teaching hospital, Riyadh, Saudi Arabia, 2001-2005.
Babay HA
Jpn J Infect Dis; 2007 May; 60(2-3):123-5. PubMed ID: 17515646
[TBL] [Abstract][Full Text] [Related]
54. Broad-spectrum beta-lactams for treating experimental peritonitis in mice due to Escherichia coli producing plasmid-encoded cephalosporinases.
Vimont S; Aubert D; Mazoit JX; Poirel L; Nordmann P
J Antimicrob Chemother; 2007 Nov; 60(5):1045-50. PubMed ID: 17804425
[TBL] [Abstract][Full Text] [Related]
55. Performance of Ceftolozane-Tazobactam Etest, MIC Test Strips, and Disk Diffusion Compared to Reference Broth Microdilution for β-Lactam-Resistant Pseudomonas aeruginosa Isolates.
Humphries RM; Hindler JA; Magnano P; Wong-Beringer A; Tibbetts R; Miller SA
J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29212704
[TBL] [Abstract][Full Text] [Related]
56. Accuracy of automated and manual systems for susceptibility testing of Pseudomonas aeruginosa to piperacillin and piperacillin-tazobactam.
Gagliotti C; Sarti M; Sabia C; Gargiulo R; Rossolini GM; Carillo C; Cassani C; Cipolloni AP; Pedna F; Rossi MR; Incerti SS; Testa G; Venturelli C; Moro ML
New Microbiol; 2011 Jan; 34(1):97-9. PubMed ID: 21344153
[TBL] [Abstract][Full Text] [Related]
57. Antimicrobial susceptibility of well-characterised multiresistant CTX-M-producing Escherichia coli: failure of automated systems to detect resistance to piperacillin/tazobactam.
Pitout JD; Le P; Church DL; Gregson DB; Laupland KB
Int J Antimicrob Agents; 2008 Oct; 32(4):333-8. PubMed ID: 18701262
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of the Vitek 2, Phoenix, and MicroScan for Antimicrobial Susceptibility Testing of Stenotrophomonas maltophilia.
Khan A; Arias CA; Abbott A; Dien Bard J; Bhatti MM; Humphries RM
J Clin Microbiol; 2021 Aug; 59(9):e0065421. PubMed ID: 34011524
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of six commercial products for colistin susceptibility testing in Enterobacterales.
Pfennigwerth N; Kaminski A; Korte-Berwanger M; Pfeifer Y; Simon M; Werner G; Jantsch J; Marlinghaus L; Gatermann SG
Clin Microbiol Infect; 2019 Nov; 25(11):1385-1389. PubMed ID: 30928563
[TBL] [Abstract][Full Text] [Related]
60. Ertapenem susceptibility of extended spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care centre in India.
Behera B; Mathur P; Das A; Kapil A
Singapore Med J; 2009 Jun; 50(6):628-32. PubMed ID: 19551319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
